Sign up for the Word on the Tree newsletter
* = required field

powered by MailChimp!

  • March 24, 2017

    The DEA awards Schedule II status to synthetic THC drug

    Pharma company gets approval for synthetic THC formulation, one man is fighting his life sentence for a marijuana offense, and more in today's newsletter.

    A pharmaceutical company's synthetic THC solution Syndros has gotten the go-ahead for Schedule II status. It is a liquid formulation of Marinol (synthetic THC in capsule form), which is currently a Schedule III substance.

  • March 1, 2017

    Republican congressman introduces bill to legalize marijuana

    Tom Garrett revives Bernie Sanders' legalization bill, Colorado's AG wants Sessions to visit the state, and more in today's newsletter.

    In president Donald Trump's joint address to Congress, he pledged to build a wall that will "slow down and ultimately stop" the "terrible drug epidemic." But evidence shows that a wall would do little to stop drug trafficking across the border.

  • February 27, 2017

    Sessions inadvertently makes an argument for cannabis legalization

    The attorney general said he is 'not a fan' of marijuana and is reviewing the Cole Memo.

    In his first briefing with reporters as attorney general, Jeff Sessions said he was looking into the Cole Memo. "I am definitely not a fan of expanded use of marijuana," he said.

  • March 15, 2017

    Sessions says weed is “slightly less awful” than heroin, vows to crack down on drugs

    'Our nation needs to say clearly once again that using drugs will destroy your life,' said the attorney general. This and more in today's newsletter.

    In a speech to law enforcement officials, attorney general Jeff Sessions "pledged aggressive criminal prosecution of drug dealers." "We have too much of a tolerance for drug use," he said, praising Nancy Reagan's 'just say no' campaign.

  • April 23, 2017

    Jeff Sessions has already hurt cannabis reform with his words alone

    Lawmakers pull back from legislation after 'threatening language' from the attorney general, pot activists say their arrests were politically motivated, and more in today's newsletter.

    Jeff Sessions hasn't made any marijuana policy changes yet. But his anti-cannabis rhetoric has lawmakers stymying voter-approved legalization and pulling back from reforms -- citing the uncertainty of the Trump administration.

  • February 8, 2017

    Cannabis-derived drug shows promise treating brain cancer

    An early-stage clinical trial had promising results, senators will vote on Sessions tonight, and more in today's newsletter.

    An early-stage clinical trial on the bio-tech company's cannabis-derived drug showed promising results for patients with glioblastoma multiforme, an aggressive form of brain cancer. The company said the data would be used to speed up its oncology research, in hopes of developing cannabinoid drugs for other types of cancer too.

  • April 7, 2017

    Report says legal weed will be fine, even if Sessions cracks down

    But others in the industry aren't so convinced

    A report from Arcview Market Research found that the cannabis industry will maintain double-digit growth even in the event of a federal crackdown. So what's with the optimism?